October 12, 2021

Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways

ATLANTA & WALTHAM, Mass.–(BUSINESS WIRE)– #healthsystems–Trellis Rx, a leading technology-enabled specialty pharmacy services provider, today announced the integration of PrismRA®, a diagnostic blood test created by Scipher Medicine® that predicts non-response to TNF Inhibitor (TNFi) therapies, into its clinical pathway for patients living with rheumatoid arthritis (RA). Scipher Medicine, the manufacturer of PrismRA, is a precision immunology company helping providers determine the most effective therapy for


Leave Comment


Your Name *
Your Email *
Your Website
Comment *